WE’RE MAKING MOVES
WITH ALYFTREK™

Watch Kristina's story about starting on ALYFTREK

Please see Important Safety Information and full Prescribing Information, including Medication Guide with Important Warning.

Explore the gallery and select a tile below to read more about experiences with ALYFTREK

People with cystic fibrosis (CF) pictured have taken ALYFTREK and were compensated for their time. Results may vary.

Quotation marks

Once-daily dosing was huge—it's so convenient for me.

Especially since ALYFTREK has to be taken with fat-containing food.

Melanie, age 44
F508del/3272-26A>G

Flip image
Patient

Melanie, age 44
F508del/3272-26A>G

X icon on hover
Quotation marks

I had a few questions for my care team.

What should I expect? 
What would be different?

Kristina, age 38
F508del/R553X

Flip image

Kristina, age 38
F508del/R553X

X icon on hover
Patient

Kristina, age 38
F508del/R553X

Flip image

My care team was very supportive about my transition to ALYFTREK.

Kristina, age 38
F508del/R553X

X icon on hover
Patient

Kristina, age 38
F508del/R553X

Flip image

ALYFTREK being able to treat more mutations really means a lot.

Kristina, age 38
F508del/R553X

X icon on hover
Quotation marks

How did you decide to start on ALYFTREK?

Flip image

Talking to my care team made me comfortable to move forward with ALYFTREK.

Melanie, age 44
F508del/3272-26A>G

X icon on hover
Quotation marks

How would you describe your experience on ALYFTREK?

Flip image

For me personally, ALYFTREK has really helped.

Melanie, age 44
F508del/3272-26A>G

X icon on hover
Quotation marks

How do you feel about once-daily dosing?

Flip image

ALYFTREK fits into my schedule and has just become part of my day.

Taking it once a day has really made a difference to me.

Kristina, age 38
F508del/R553X

X icon on hover

Melanie, age 44
F508del/3272-26A>G

Flip image

I hope ALYFTREK can help people with more mutations.

Melanie, age 44
F508del/3272-26A>G

X icon on hover

Ask your healthcare 
provider about
ALYFTREK

ISI-VANZA

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about ALYFTREK?

Elevated liver enzymes have been observed in patients taking ALYFTREK. Cases of serious liver damage and liver failure leading to transplantation and death have been seen in some people with or without a history of liver problems taking elexacaftor/‌‌tezacaftor/‌‌ivacaftor (TRIKAFTA®), a medicine which has the same or similar active ingredients as ALYFTREK.

  • Your healthcare provider will do blood tests to check your liver:
    • before you start ALYFTREK
    • every month during your first 6 months of taking ALYFTREK
    • then every 3 months during the next 12 months of taking ALYFTREK
    • then at least every year while you are taking ALYFTREK

What is ALYFTREK™ (vanzacaftor/‌tezacaftor/‌deutivacaftor)?

ALYFTREK is a prescription medicine used for the treatment of cystic fibrosis (CF) in people aged 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Talk to your healthcare provider to learn if you have an indicated CF gene mutation.

It is not known if ALYFTREK is safe and effective in children under 6 years of age.

  • Your healthcare provider may do blood tests to check the liver more often if you have had high liver enzymes in your blood in the past or are experiencing signs or symptoms of liver injury
  • Stop taking ALYFTREK and call your healthcare provider right away if you have any of the following symptoms of liver problems:
    • pain, swelling, or discomfort in the upper right stomach (abdominal) area
    • yellowing of your skin or the white part of your eyes
    • mental changes
    • nausea or vomiting
    • dark, amber-colored urine
    • loss of appetite
    • fluid in your stomach area (ascites)
What should I tell my healthcare provider before taking ALYFTREK?

Before taking ALYFTREK, tell your healthcare provider about all of your medical conditions, including if you: 

  • have or have had liver problems
  • are allergic to ALYFTREK or any ingredients in ALYFTREK. See the Medication Guide for a complete list of ingredients in ALYFTREK
  • have taken another medicine with elexacaftor, tezacaftor, or ivacaftor before and temporarily or permanently stopped because of side effects. Your healthcare provider may want to see you more often
  • have kidney problems
  • are pregnant or plan to become pregnant. It is not known if ALYFTREK will harm your unborn baby. You and your healthcare provider should decide if you will take ALYFTREK while you are pregnant
  • are breastfeeding or planning to breastfeed. It is not known if ALYFTREK passes into your breast milk. You and your healthcare provider should decide if you will take ALYFTREK while you are breastfeeding

Tell your healthcare provider about all the medicines you take, including prescription and over‑the‑counter medicines, vitamins, and herbal supplements.

ALYFTREK may affect the way other medicines work, and other medicines may affect how ALYFTREK works. The dose of ALYFTREK may need to be adjusted when taken with certain medicines. Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What should I avoid while taking ALYFTREK?
  • Avoid food or drink that contains grapefruit while you are taking ALYFTREK
What are the possible or reasonably likely side effects of ALYFTREK?

ALYFTREK can cause serious side effects, including:

  • See “What is the most important information I should know about ALYFTREK?”
  • Serious Allergic Reactions can happen to people who are treated with ALYFTREK. Call your healthcare provider or go to the emergency room right away if you have any symptoms of an allergic reaction. Symptoms of an allergic reaction may include:
    • rash or hives
    • tightness of the chest or throat or difficulty breathing
    • light-headedness or dizziness
  • Abnormality of the eye lens (cataract) has happened in some children and adolescents treated with ALYFTREK. If you are a child or adolescent, your healthcare provider should perform eye examinations before and during treatment with ALYFTREK to look for cataracts

The most common side effects of ALYFTREK include:

  • cough
  • pain or swelling of your nose or throat (nasopharyngitis)
  • upper respiratory tract infection (common cold) including stuffy and runny nose
  • headache
  • mouth or throat pain
  • flu (influenza)
  • tiredness
  • increase in liver enzymes
  • rash
  • sinus congestion

Your healthcare provider should monitor you during treatment with ALYFTREK. You may require additional monitoring if your treatment with a medicine that works like ALYFTREK has been previously stopped or interrupted because of side effects.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all of the possible side effects of ALYFTREK. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Medication Guide with Important Warning.